Hematopoietic malignancies demonstrate loss-of-function mutations of BAX
about
The Bcl-2 apoptotic switch in cancer development and therapyBAX unleashed: the biochemical transformation of an inactive cytosolic monomer into a toxic mitochondrial poreCancer's Achilles' Heel: Apoptosis and Necroptosis to the RescueOncogenic kit triggers Shp2/Erk1/2 pathway to down-regulate the pro-apoptotic protein Bim and to promote apoptosis resistance in leukemic cellsBax loss impairs Myc-induced apoptosis and circumvents the selection of p53 mutations during Myc-mediated lymphomagenesisApoptosis triggered by Myc-induced suppression of Bcl-X(L) or Bcl-2 is bypassed during lymphomagenesisDirect Activation of Bax Protein for Cancer TherapyA stapled BIM peptide overcomes apoptotic resistance in hematologic cancers.Endogenous Bak inhibitors Mcl-1 and Bcl-xL: differential impact on TRAIL resistance in Bax-deficient carcinoma.Morusin induces apoptosis by regulating expression of Bax and Survivin in human breast cancer cells.Molecular detection of the G(-248)A BAX promoter nucleotide change in B cell chronic lymphocytic leukaemiaMCL1 and BCL-xL levels in solid tumors are predictive of dinaciclib-induced apoptosis.Disruption of the VDAC2-Bak interaction by Bcl-x(S) mediates efficient induction of apoptosis in melanoma cells.Quantitative expression analysis and prognostic significance of the BCL2-associated X gene in nasopharyngeal carcinoma: a retrospective cohort study.Sialylation of the Fas death receptor by ST6Gal-I provides protection against Fas-mediated apoptosis in colon carcinoma cellsThe essential role of evasion from cell death in cancer.Nonredundant role of Bax and Bak in Bid-mediated apoptosis.BAX pro-apoptotic gene alterations in repeated pregnancy loss.SATB1 Mediates Long-Range Chromatin Interactions: A Dual Regulator of Anti-Apoptotic BCL2 and Pro-Apoptotic NOXA GenesProapoptotic BID is required for myeloid homeostasis and tumor suppression.Multifunctional magnetic Fe3O4 nanoparticles combined with chemotherapy and hyperthermia to overcome multidrug resistance.Bodyguards and assassins: Bcl-2 family proteins and apoptosis control in chronic lymphocytic leukaemia.Bcl-2-family proteins and hematologic malignancies: history and future prospects.InSite: a computational method for identifying protein-protein interaction binding sites on a proteome-wide scale.Expression of Apoptosis-regulating Proteins Bcl-2 and Bax in Lymph Node Aspirates from Dogs with Lymphoma.Mutational inactivation of the proapoptotic gene BAX confers selective advantage during tumor clonal evolution.Mimicking the BH3 domain to kill cancer cellsPATZ1 expression correlates positively with BAX and negatively with BCL6 and survival in human diffuse large B cell lymphomas.Getting away with murder: how does the BCL-2 family of proteins kill with immunity?Death receptors as targets in cancerOncolytic virotherapy and immunogenic cancer cell death: sharpening the sword for improved cancer treatment strategiesTargeting the mitochondrial apoptotic pathway: a preferred approach in hematologic malignancies?Manganese superoxide dismutase gene dosage affects chromosomal instability and tumor onset in a mouse model of T cell lymphoma.Abnormal intracellular localization of Bax with a normal membrane anchor domain in human lung cancer cell lines.Loss of BCL-2 in the progression of oral cancer is not attributable to mutations.Directly targeting the mitochondrial pathway of apoptosis for cancer therapy using BH3 mimetics - recent successes, current challenges and future promise.Mutagenesis of the BH3 domain of BAX identifies residues critical for dimerization and killing.Integrated mate-pair and RNA sequencing identifies novel, targetable gene fusions in peripheral T-cell lymphoma.Genetic and functional characterization of disease associations explains comorbidity.The p53-Bcl-2 connection.
P2860
Q24620437-38ECEA23-6F4F-4678-B3C0-201549B5449CQ27002044-C28927D4-5B19-49ED-A6D9-4E40C76AE527Q28066868-E80C2164-CF46-4D11-A8FF-5580E0BAE011Q28484910-B5F03B4E-0E56-4539-9773-7455370A8BE7Q28513038-F4C58E26-A5B2-4BA8-ABFE-7D4A3E2E700CQ28593886-ADDCB3A6-83F9-4F1F-BE69-37CF19E283BAQ30353924-36504A3E-E21A-461C-BAA4-5ADC01E44B03Q30466831-BF80F947-8BDB-4A11-A327-79D83465801CQ33544118-81BEAE60-D440-4B19-9B29-F260EA310B71Q33751157-A16B1AB2-01F8-4FE1-BB37-DCAD7A01B279Q33919200-236F1F27-B677-4678-8A73-90465AD4DF75Q34301314-73809A66-1D57-402F-BB58-15F75A2FB030Q34306986-81E3ED2F-CEB7-4A11-BE44-0605608020F4Q34777413-CEF4633A-AECB-4385-AB76-A27E5619CC53Q35067731-12047EFD-6C2F-44E0-85FE-F46B4B41F8B2Q35083049-741B9738-552D-4CEB-A13B-FBA4E928F429Q35150716-6B731B98-7D20-4E04-953A-A019866F9DC0Q35673934-2A14F301-E03E-4714-BF79-A8E82BC3FBADQ35793778-2980F813-4056-491E-8D90-388BCD54F172Q35963747-35C87541-AE50-4321-99FD-D3D9F07D9EFCQ35972702-C77E98A5-2337-455C-9C19-5157D575DBFCQ36085962-58FE9E70-EF1C-4EC3-BA1E-932C3FDEBA34Q36508817-D973B326-5AB1-41EF-A40C-9A48690AF5F1Q36643290-C4E3FFD7-B94A-4773-A863-E23BFC9F46AEQ37020239-4EA9C7FF-BB63-42E9-97A7-4A23BBCD28A5Q37264027-2CE750F2-AECE-43FA-AD4A-56B28330045AQ37566211-C0D56123-6A19-40A6-85CB-D41474F4764FQ37644833-EED9DD7F-EA42-4D2B-A3A7-FCB19C91F4ACQ38092837-47D48546-B6FF-4AB4-A461-F627D9A79E4AQ38103591-0BAB8BFB-4BAE-470C-A3D9-3F3092C706BDQ38139255-ED5F0A3A-8BAA-43E5-B4E8-DED4FEE78AF8Q38193997-A5FA3B4F-1727-4479-B2B1-BC3B4E66DE79Q38276483-934E12C8-CB4F-40D8-8C89-BC898605EFD9Q38305678-3A45E2A9-E939-4396-BC33-D122BE116EF3Q38440406-EB776260-78F2-4325-8828-F049977D0104Q38782374-26543580-8A9E-4CC1-813A-3BB5BFB47511Q39576297-662BA0F0-FE27-4202-B4EB-FEDDB6EFD13CQ41004137-34727485-8E5C-4BB4-AE3B-F3DEF9605EDCQ41108481-79C0C626-D942-40A8-AE54-E65E64E788A8Q41489275-EAABFAED-01A3-4CE2-B0F1-EB7995DEBC05
P2860
Hematopoietic malignancies demonstrate loss-of-function mutations of BAX
description
1998 nî lūn-bûn
@nan
1998 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Hematopoietic malignancies demonstrate loss-of-function mutations of BAX
@ast
Hematopoietic malignancies demonstrate loss-of-function mutations of BAX
@en
Hematopoietic malignancies demonstrate loss-of-function mutations of BAX
@en-gb
Hematopoietic malignancies demonstrate loss-of-function mutations of BAX
@nl
type
label
Hematopoietic malignancies demonstrate loss-of-function mutations of BAX
@ast
Hematopoietic malignancies demonstrate loss-of-function mutations of BAX
@en
Hematopoietic malignancies demonstrate loss-of-function mutations of BAX
@en-gb
Hematopoietic malignancies demonstrate loss-of-function mutations of BAX
@nl
prefLabel
Hematopoietic malignancies demonstrate loss-of-function mutations of BAX
@ast
Hematopoietic malignancies demonstrate loss-of-function mutations of BAX
@en
Hematopoietic malignancies demonstrate loss-of-function mutations of BAX
@en-gb
Hematopoietic malignancies demonstrate loss-of-function mutations of BAX
@nl
P2093
P3181
P1433
P1476
Hematopoietic malignancies demonstrate loss-of-function mutations of BAX
@en
P2093
A W Slöetjes
E J Mensink
J P Meijerink
S J Korsmeyer
T W Sedlak
T de Witte
P304
P3181
P407
P577
1998-04-15T00:00:00Z